Good morning :)
Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

AGARWALEYE Share Price

NSE
₹500.450.53% (-2.65)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Hospitals & Diagnostic Centres
Smallcap

With a market cap of ₹15,865 cr, stock is ranked 449

Moderate Risk

Stock is 2.05x as volatile as Nifty

AGARWALEYE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Hospitals & Diagnostic Centres
Smallcap

With a market cap of ₹15,865 cr, stock is ranked 449

Moderate Risk

Stock is 2.05x as volatile as Nifty

AGARWALEYE Performance & Key Metrics

AGARWALEYE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
106.937.48—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.205.920.48%

AGARWALEYE Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 5 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

AGARWALEYE Company Profile

Dr. Agarwal's Health Care Ltd operates eye care hospitals and provides a comprehensive range of eye care services, including surgeries, consultations, and optical products.

Investor Presentation

View older View older 

Aug 4, 2026

PDF
View Older Presentations

AGARWALEYE Similar Stocks (Peers)

Compare with peers Compare with peers 

AGARWALEYE Similar Stocks (Peers)

Compare with peers Compare with peers 
Apollo Hospitals Enterprise Limited
APOLLOHOSP
PE Ratio
66.23
66.23
1Y Return
13.94%
13.94%
Buy Reco %
86.67
86.67
Max Healthcare Institute Limited
MAXHEALTH
PE Ratio
70.80
70.80
1Y Return
10.58%
10.58%
Buy Reco %
83.33
83.33
Manipal Health Enterprises Limited
MANIPALHOS
PE Ratio
108.93
108.93
1Y Return
10.80%
10.80%
Buy Reco %
62.50
62.50
Fortis Healthcare Ltd
FORTIS
PE Ratio
64.21
64.21
1Y Return
8.51%
8.51%
Buy Reco %
90.00
90.00
Aster DM Quality Care Limited
ASTERDM
PE Ratio
169.57
169.57
1Y Return
22.99%
22.99%
Buy Reco %
90.91
90.91
Compare with Peers

AGARWALEYE Sentiment Analysis

AGARWALEYE Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

AGARWALEYE Stock Summary · August 2026

Management described Q1 FY27 as a strong start to the year, with record quarterly revenue, EBITDA and margins all improving year on year even as greenfield losses from recent facility additions weighed on profitability. The quarter was supported by robust operating activity, including more than 8.8 lakh patients and nearly 91,000 surgeries, up 15.5% year on year, while revenue growth outpaced surgical volumes, reflecting a favorable mix and better realization. Management emphasized expansion as a core priority, commissioning 18 new greenfield facilities in the quarter, lifting the India network to 285 facilities across 14 states and 5 union territories, and noting continued room to scale newer centers. Premiumization and selective price increases contributed about 8% of growth, with average cataract realization rising to around INR42,000 from roughly INR28,000–INR30,000 four years ago. At the same time, doctor and employee costs rose with the rollout, though finance expense declined. Looking ahead, management said 12 more facilities are planned for Q2 and 30 in the second half, supported by more than 30 signed LOIs.

AGARWALEYE Stock Growth Drivers
AGARWALEYE Stock Growth Drivers
8
  • Record Revenue, EBITDA and Margin Expansion

    The company delivered a strong Q1 FY27 performance, with revenue from operations rising 26% year

  • Rapid Network Expansion and Execution Strength

    Expansion remained a clear positive, with the company commissioning a record 18 greenfield facilities in

AGARWALEYE Stock Challenges
AGARWALEYE Stock Challenges
2
  • Greenfield and Pre-Operating Center Losses

    Recently launched and pre-operating centers are still a meaningful drag on profitability, with corporate EBITDA

  • Elevated Doctor Attrition

    Doctor attrition remains high at roughly 16% to 17% at the group level, signaling ongoing

end marker

AGARWALEYE Forecast

AGARWALEYE Forecasts

Price

Revenue

Earnings

AGARWALEYE Share Price Forecast

AGARWALEYE Share Price Forecast

2026
Current
₹500.45
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2026
Current
₹500.45
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

AGARWALEYE Company Revenue Forecast

AGARWALEYE Company Revenue Forecast

2026
Current
₹2.13
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

Loading...
2026
Current
₹2.13
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

AGARWALEYE Stock EPS (Earnings Per Share) Forecast

AGARWALEYE Stock EPS (Earnings Per Share) Forecast

2026
Current
₹4.21
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2026
Current
₹4.21
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

AGARWALEYE

AGARWALEYE

Income

Balance Sheet

Cash Flow

AGARWALEYE Income Statement

AGARWALEYE Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue369.07409.49428.45443.43475.65500.81506.62540.40578.02620.43
Operating & Other expensessubtract240.81299.87309.60315.91331.73359.56362.55385.76402.64443.61
Depreciation/Amortizationsubtract46.7055.5157.1858.1860.3962.9567.8668.7576.6878.31
Interest & Other Itemssubtract27.3927.0328.4028.3525.0124.7022.5521.1322.0823.37
Taxes & Other Itemssubtract15.4215.1016.6918.6525.9523.5523.9731.0236.9129.91
EPS1.390.430.450.731.040.950.941.071.251.43
See Costs

EPS in ₹. Other numbers in ₹ cr

AGARWALEYE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Aug 4PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 21PDF
Feb 3PDF
Oct 31PDF
Aug 12PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 29PDF
Feb 17PDF
 

AGARWALEYE Stock Peers

AGARWALEYE Past Performance & Peer Comparison

AGARWALEYE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dr. Agarwal's Health Care Limited119.127.48—
Apollo Hospitals Enterprise Limited66.2312.890.22%
Max Healthcare Institute Limited70.809.500.19%
Manipal Health Enterprises Limited108.9311.05—

AGARWALEYE Stock Price Comparison

Compare AGARWALEYE with any stock or ETF
Compare AGARWALEYE with any stock or ETF
AGARWALEYE
Loading...

AGARWALEYE Holdings

AGARWALEYE Shareholdings

AGARWALEYE Promoter Holdings Trend

AGARWALEYE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AGARWALEYE Institutional Holdings Trend

AGARWALEYE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AGARWALEYE Shareholding Pattern

AGARWALEYE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding32.34%6.02%1.70%57.96%1.98%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

AGARWALEYE Shareholding History

AGARWALEYE Shareholding History

MarJunSepDec '25MarJun60.62%59.26%58.13%58.06%57.94%57.96%

Mutual Funds Invested in AGARWALEYE

Mutual Funds Invested in AGARWALEYE

No mutual funds holding trends are available

Top 5 Mutual Funds holding Dr. Agarwal's Health Care Limited

Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Invesco India Smallcap Fund - Growth - Direct Plan

Growth
2.4250%2.44%0.90%44/76 (+8)
ICICI Prudential Aggressive Hybrid Fund - Growth - Direct Plan

Growth
1.5721%0.48%0.48%260/290 (+22)
Motilal Oswal Small Cap Fund - Growth - Direct Plan

Growth
1.5628%3.04%0.09%4/70 (+1)

Compare 3-month MF holding change on Screener

AGARWALEYE Insider Trades & Bulk Stock Deals

AGARWALEYE Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AGARWALEYE stock

smallcases containing AGARWALEYE stock

Looks like this stock is not in any smallcase yet.

AGARWALEYE Events

AGARWALEYE Events

AGARWALEYE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AGARWALEYE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AGARWALEYE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AGARWALEYE has not given any dividends in last 5 years

AGARWALEYE Dividends

AGARWALEYE Dividends

Hmm, looks like data is unavailable here. Please come back after some time

AGARWALEYE Stock News & Opinions

AGARWALEYE Stock News & Opinions

Earnings
Earnings
Dr Agarwals Health Care Ltd consolidated sales up 8.85% on year in Q2FY2026, net profit improved by 10.13%

Dr Agarwals Health Care Ltd share price inched up 0.97% to Rs 483.75 after the company's net profit expanded by 10.13% to Rs 55.02 crore, while revenue from operations slightly gained 8.85% to Rs 614.02 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.05 lakh crore, easing 4.07%. It has eased by 0.51% over last one week and jumped by 15.67% in last one month while the market capitalization of Dr Agarwals Health Care Ltd has softened by 1.71% and 5.61% in the same period respectively. Profit before tax (PBT) of Dr Agarwals Health Care Ltd stood at Rs 75.14 crore in Q2 FY26, expanding by 40.19% year-on-year, and declining 1.93% quarter-on-quarter. EBITDA came in at Rs 164 crore, rallying 43.27% YoY and climbing 10.15% sequentially. Total expenses saw a slight increase of 8.89% to Rs 521.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.32 crore, witnessing a sharp rise of 33.33% YoY, while employee benefits expense was at Rs 121.04 crore, jumping 16.62% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 28.44% to Rs 1711.0 crore, while net profit registered a growth of 16.09% to Rs 110.34 crore, compared to previous TTM. EBITDA jumped by 37733% to Rs 410.36 crore, and PBT improved 13.72% to Rs 159.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 360.33 crore in FY26, as against Rs 345.96 crore in FY25. Dr Agarwals Health Care Ltd advanced by 5.53% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.94% during the same period.

1 month agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to conduct board meeting

Dr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 4 August 2026.

1 month agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to conduct board meeting

Dr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 4 August 2026.

1 month agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care allots 43,155 equity shares under ESOS

Dr Agarwals Health Care has allotted 43,155 equity shares under ESOS on 09 July 2026. Consequently, the paid up equity share capital has increased to 31,70,26,183 equity shares of Re 1 each.

2 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to conduct EGM

Dr Agarwal's Health Care announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 July 2026.

3 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to conduct EGM

Dr Agarwals Health Care announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 July 2026.

3 months agoCapital Market - Live
Earnings
Earnings
Dr Agarwal's Health Care consolidated net profit rises 21.92% in the March 2026 quarter

Net profit of Dr Agarwal's Health Care rose 21.92% to Rs 39.71 crore in the quarter ended March 2026 as against Rs 32.57 crore during the previous quarter ended March 2025. Sales rose 22.57% to Rs 564.11 crore in the quarter ended March 2026 as against Rs 460.22 crore during the previous quarter ended March 2025. For the full year,net profit rose 59.59% to Rs 133.19 crore in the year ended March 2026 as against Rs 83.46 crore during the previous year ended March 2025. Sales rose 21.57% to Rs 2080.08 crore in the year ended March 2026 as against Rs 1711.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales564.11460.22 23 2080.081711.00 22 OPM %28.6228.46 -27.3826.67 - PBDT151.97121.41 25 523.55393.61 33 PBT75.2961.02 23 247.31162.87 52 NP39.7132.57 22 133.1983.46 60 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwal's Health Care to declare Quarterly Results

Dr Agarwal's Health Care will hold a meeting of the Board of Directors of the Company on 21 May 2026.

4 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care to declare Quarterly Results

Dr Agarwals Health Care will hold a meeting of the Board of Directors of the Company on 21 May 2026.

4 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Health Care allots 1.50 lakh equity shares under ESOS

Dr Agarwals Health Care has allotted 1,50,282 equity shares under ESOS on 08 April 2026. With this allotment, the paid up equity share capital has increased to Rs 31,69,57,788 consisting of 31,69,57,778 equity shares of Re 1 each.

5 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of AGARWALEYE as on 18th September 2026 is ₹500.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Dr. Agarwal's Health Care Limited (AGARWALEYE) share are
    • Past 1 week: 0.18%
    • Past 1 month: 0.28%
    • Past 3 months: 12.51%
    • Past 6 months: 15.32%
    • Past 1 year: 12.70%
    • Past 3 years: N/A%
    • Past 5 years: 24.60%

  3. The peers or stocks similar to Dr. Agarwal's Health Care Limited (AGARWALEYE) include:

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr. Agarwal's Health Care Limited (AGARWALEYE) is ₹15865.58 Cr as of 18th September 2026.

  5. The 52-week high of Dr. Agarwal's Health Care Limited (AGARWALEYE) is ₹568 and the 52-week low is ₹401.

  6. The P/E (price-to-earnings) ratio of Dr. Agarwal's Health Care Limited (AGARWALEYE) is 119.12. The P/B (price-to-book) ratio is 7.48.

  7. Dr. Agarwal's Health Care Limited (AGARWALEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. You can directly buy Dr. Agarwal's Health Care Limited (AGARWALEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.